Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Other Non-Current Assets (2010 - 2026)

Updated

Northwest Biotherapeutics (NWBO) posted Other Non-Current Assets of $354,000 for Q2 2026, down 4.3% from $370,000 a year earlier and unchanged from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Other Non-Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Northwest Biotherapeutics' Other Non-Current Assets came in at $356,000, down 2.5% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of -16.3% (FY2020 to FY2025).
  • In prior years, Northwest Biotherapeutics' Other Non-Current Assets was $365,000 in FY2024 (+1.1%), $361,000 in FY2023 (+4.6%), $345,000 in FY2022 (-66.7%) and $1.04 million in FY2021 (+19.5%).
  • Quarterly Other Non-Current Assets has run from a low of $339,000 in Q3 2022 to a high of $1.05 million in Q3 2021 over five years.
  • On a year-over-year basis, Other Non-Current Assets has declined in each of the last five quarters, with an average decline of 1.0% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q3 2021, with growth of 31.1%; the weakest was Q2 2022, with a decline of 68.7%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $354,000 (Q1 2026), $356,000 (Q4 2025) and $358,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - 354,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 354,000.00
Mar 31, 2026 354,000.00
Dec 31, 2025 356,000.00
Sep 30, 2025 358,000.00
Jun 30, 2025 370,000.00
Mar 31, 2025 367,000.00
Dec 31, 2024 365,000.00
Sep 30, 2024 374,000.00
Jun 30, 2024 372,000.00
Mar 31, 2024 363,000.00
Dec 31, 2023 361,000.00
Sep 30, 2023 357,000.00
Jun 30, 2023 361,000.00
Mar 31, 2023 362,000.00
Dec 31, 2022 345,000.00
Sep 30, 2022 339,000.00
Jun 30, 2022 342,000.00
Mar 31, 2022 349,000.00
Dec 31, 2021 1.04 Mn
Sep 30, 2021 1.05 Mn
API Access

Northwest Biotherapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NWBO&period=max&api_key=YOUR_API_KEY